2026. Β-CARYOPHYLLENE AS A PARTNER FOR DOXORUBICIN: EVIDENCE FOR CHEMOSENSITISATION, TISSUE PROTECTION AND LIPID-BASED CO-DELIVERY. Frontier in Medical and Health Research. 4, 3 (Mar. 2026), 4636–4645.